Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2573PDF: 736HTML: 2297 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2213PDF: 1044HTML: 1981Characteristic of study group: 196 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1483PDF: 767HTML: 202 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2173PDF: 2002HTML: 173 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2448PDF: 783HTML: 1735 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
2943PDF: 889HTML: 1912 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3266PDF: 1236HTML: 8104 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1518PDF: 535HTML: 270 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2119PDF: 1690HTML: 376 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1824PDF: 715HTML: 2105Untitled: 215Untitled: 152Untitled: 171Untitled: 154Untitled: 163Untitled: 178Untitled: 183 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2189PDF: 1483HTML: 264 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2094PDF: 990HTML: 4069Cover Letter: 221Figure 1: 233Figure 2: 230Table 1: 204 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1024PDF: 1197Suppl. Files: 146HTML: 69 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7428PDF: 2419HTML: 1730Table 1.: 208Table 2.: 217Table 3.: 201Table 4.: 200 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1037PDF: 1153Suppl. Files: 569HTML: 85 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3766PDF: 1653HTML: 11581Figures Haase: 198 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3903Suppl. Files: 1107PDF: 1061Html: 174 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
937PDF: 570HTML: 2190Cover Letter: 190 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3579PDF: 883HTML: 6710 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4291PDF: 1369HTML: 2039 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4308PDF: 1487HTML: 1547Untitled: 225 -
UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
2362PDF: 1388HTML: 1979 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3544PDF: 1568HTML: 80 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
3551PDF: 1066HTML: 874







